Asia Pacific (APAC) Drug Delivery Devices Market - Trends and Forecast to 2024

Asia Pacific Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) – Industry Trends and Forecast to 2024

APAC Drug Delivery Devices Market is expected to reach USD 235.8 billion by 2024 from USD 130.9 billion in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.

Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-apac-drug-delivery-devices-market

• On the basis of route of administration the APAC drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
• The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups.
• The Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
• The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. Based on the route of administration, oral drug delivery market dominates the market in 2015 and in the near future injectable drug delivery market will dominate the APAC drug delivery devices market with the largest share in the drug delivery market. Topical drug delivery market is considered to be the fastest growing market with the CAGR of 11.5%.

Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-apac-drug-delivery-devices-market

The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.

Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.

Nasal drug delivery devices are segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sunlingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

On the basis of end users the APAC drug delivery devices market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the North America drug delivery devices market.

The major factors contributing to the growth of the APAC drug delivery devices market are rising prevalence of chronic diseases, growing geriatric population, increase in diagnosis, growth of biosimilars, new product launches, drug innovation, technological advancements, and decrease in the level of pain. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.

Compotator

The major players covered in the report are Alcoa Corporation, Endurance Technologies Limited, Ryobi Limited, DyCast Specialties Corporation, Consolidated Metco, Inc., Alcast Technologies, Ningbo Beilun Create Mould Machine Co., Ltd, Leggett & Platt, Incorporated, Martinrea Honsel Germany GmbH, Gibbs, Dynacast, Reliance Foundry Co. Ltd., Toyota Industries Corporation, LA Aluminum, TPi Arcade, Drahtwerk Elisental W. Erdmann GmbH & Co., Wagstaff Inc., Ningbo Innovaw Mechanical CO.,LTD., Modern Aluminum Castings CO., INC. and Pacific Die Casting Corp.

Request for Toc@https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-apac-drug-delivery-devices-market

Global Asia Pacific (APAC) Drug Delivery Devices Market Size, Status and Forecast 2018 – 2025

1. Market Overview
2. Manufacturers Profiles
3. Global APAC Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer
4. Global APAC Cancer Diagnostics Market Analysis by Regions
5. North America Global APAC Cancer Diagnostics by Countries
6. Europe Global Asia Pacific (APAC) Drug Delivery Devices by Countries
7. Asia-Pacific Asia Pacific (APAC) Drug Delivery Devices by Countries
8. South America Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
9. Middle East and Africa Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
10. APAC Cancer Diagnostics Market Segment by Type
11. Global Asia Pacific (APAC) Drug Delivery Devices Market Segment by Application
12. Global APAC Cancer Diagnostics Market Forecast
13. Sales Channel, Distributors, Traders and Dealers
14. Research Findings and Conclusion
15. Appendixes

Based on geography the market is segmented into 7 countries, China, India, Japan, South Korea, Singapore, Australia and rest of APAC. Japan is expected to dominate the market, while China and India are expected to be the growing with highest CAGR in the forecast period.

The report also includes company share analysis for the major companies operating in this market by countries. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report. Some of the players in the market Bayer AG, Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co., Sanofi, Antares Pharma, and 3M.

Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-apac-drug-delivery-devices-market

Reasons to Purchase this Report

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

• Amyotrophic Lateral Sclerosis (ALS) Market
• a href="file:///C:/Users/Computer_W10/AppData/Roaming/Microsoft/Word/Antifungal%20Drugs%20Market"> Antifungal Drugs Market

• a href="file:///C:/Users/Computer_W10/AppData/Roaming/Microsoft/Word/Cutaneous%20Lupus%20Erythematosus%20Market">Cutaneous Lupus Erythematosus Market

Global 1,6 hexanediol market is estimated to reach Usd 1525.16 million with a substantial Cagr of 7.5% by the end of 2026. This rise in market value can be attributed due to wide applications of end products, growth in the wind energy sector